Aurobindo Pharma Q1 Results
- BSE: 524804
- NSE: AUROPHARMA
- ISIN: INE406A01037
- Sector: Major Drugs
BSE
1,461.65
9.80 (0.68%)
9.80 (0.68%)Volume9.06 K
Updated: Tue 9 Jun, 2026 | 11:49:31
NSE
1,462.4010.60 (0.73%)
10.60 (0.73%)Volume2.33 L
Updated: Tue 9 Jun, 2026 | 11:34:32
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - Aurobindo Pharma Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 26 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 6,670.42 | 7,530.97 | -5.48% | 6,351.63 | 5.02% |
| Depreciation/ Amortization | 405.70 | 478.57 | -8.71% | 404.18 | 0.38% |
| Operating Income | 1,197.72 | 1,322.37 | -9.60% | 1,215.39 | -1.45% |
| Net Income | 824.75 | 921.26 | -8.71% | 919.22 | -10.28% |
| Other Operating Expenses Total | 1,796.70 | 2,249.35 | -11.16% | 1,802.82 | -0.34% |
| Net Income Before Taxes | 1,206.80 | 1,290.61 | -9.61% | 1,323.89 | -8.84% |
| Total Revenue | 7,868.14 | 8,853.34 | -6.13% | 7,567.02 | 3.98% |
| Selling/ General/ Admin Expenses Total | 1,228.80 | 1,373.98 | 5.69% | 1,071.95 | 14.63% |
| Diluted Normalized EPS | 14.20 | 15.86 | -8.73% | 15.69 | -9.50% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
âś•
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.